- 2022 American Transplant Congress - Low-Dose Aspirin is More Critical Than Statins in Preventing Transplant Renal Artery Stenosis- Urology, Henan Provincial People's Hospital, Zhengzhou, China *Purpose: To explore the clinical value of low-dose aspirin (100mg) and statins (10 ~ 20mg) in the prevention of transplant renal artery stenosis (TRAS).*Methods: A…
- 2022 American Transplant Congress - Low-Dose Aspirin is Effective in Preventing Transplant Renal Artery Stenosis: A Prospective Randomized Controlled Trial- Henan Provincial People's Hospital, Zhengzhou, Henan Province, China *Purpose: Transplant renal artery stenosis (TRAS), the most common post-transplant vascular complication, leads to resistant hypertension, renal impairment, and even graft loss. No effective prophylactic…
- 2022 American Transplant Congress - Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series*Purpose: Ex vivo normothermic perfusion (EVNP) is increasingly recognized as a viability tool to increase organ utilization. We report use of EVNP to assess graft…
- 2021 American Transplant Congress - Risk Factors and Outcome of Transplant Renal Artery Stenosis in Kidney Transplant Recipients – A Nested Case-control Study*Purpose: Transplant renal artery stenosis (TRAS) is a treatable cause of renal allograft dysfunction. It presents commonly in the early post-transplant period with variable clinical…
- 2021 American Transplant Congress - Single Center Experience in Ex Vivo Hilar Renal Artery Aneurysm Repair and Autotransplantation*Purpose: In this study, we review our centers experience with complex renal artery aneurysms using our preferred technique of open nephrectomy, ex vivo repair, and…
- 2020 American Transplant Congress - Time for Change: Assessment of Renal Transplant Artery Stenosis with N.A.T.I.V.E. True-F.I.S.P. and N.A.T.I.V.E. G.R.E*Purpose: Non-contrast MRA can be fraught with artifact and lack of signal both in areas of stenosis as well as normal vessels. Therefore, it is…
- 2018 American Transplant Congress - De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation- University of Wisconsin, Madison. Third party ABO-compatible vessel allografts (VA) are sometimes used as extension vessels for kidney and pancreas transplants (TX). The frequency and implications of de novo…
- 2017 American Transplant Congress - Fibromuscular Dysplasia in Living Kidney Donors: Characteristics and Recipient Outcomes.Introduction: Presence of incidentally detected fibromuscular dysplasia (FMD) is a challenging and controversial issue for selection of living kidney donors (LKD). Whether donors with FMD…
- 2017 American Transplant Congress - Classification of Fibromuscular Dysplasia in Kidney Donors Based on Severity and Extent of Lesion.Introduction: Selection of living kidney donors (LKD) with renal artery (RA) fibromuscular dysplasia (FMD) is controversial, as traditional diagnostic classifications lack estimates on FMD severity.…
- 2017 American Transplant Congress - Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…
